1 |
PIMPLE S A, MISHRA G A. Global strategies for cervical cancer prevention and screening[J]. Minerva ginecologica, 2019, 71(4): 313-320.
|
2 |
HU Z, MA D. The precision prevention and therapy of HPV-related cervical cancer: New concepts and clinical implications[J]. Cancer medicine, 2018, 7(10): 5217-5236.
|
3 |
PLUMMER M, DE MARTEL C, VIGNAT J, et al. Global burden of cancers attributable to infections in 2012: A synthetic analysis[J]. The lancet global health, 2016, 4(9): e609- e616.
|
4 |
ARBYN M, WEIDERPASS E, BRUNI L, et al. Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis[J]. The lancet global health, 2020, 8(2): e191-e203.
|
5 |
王翠霞. HPV单一感染与多重感染对宫颈病变的影响[J]. 中国卫生标准管理, 2021, 12(4): 17-19.
|
6 |
ROMAN B R, ARAGONES A. Epidemiology and incidence of HPV-related cancers of the head and neck[J]. Journal of surgical oncology, 2021, 124(6): 920-922.
|
7 |
ZHANG R, SHEN C, ZHAO L, et al. Dysregulation of host cellular genes targeted by human papillomavirus (HPV) integration contributes to HPV-related cervical carcinogenesis[J]. International journal of cancer, 2016, 138(5): 1163-1174.
|
8 |
WANG X I, THOMAS J, ZHANG S. Changing trends in human papillomavirus-associated head and neck squamous cell carcinoma[J]. Annals of diagnostic pathology, 2012, 16(1): 7-12.
|
9 |
MEDEIROS R, VAZ S, REBELO T, et al. Prevention of human papillomavirus infection. Beyond cervical cancer: A brief review[J]. Acta médica portuguesa, 2020, 33(3): 198-201.
|
10 |
WEI L, XIE X, LIU J, et al. Elimination of cervical cancer: Challenges promoting the HPV vaccine in China[J]. Indian journal of gynecologic oncology, 2021, 19(3): 51.
|
11 |
CASTELLSAGUÉ X, BOSCH F X, MUÑOZ N. Environmental co-factors in HPV carcinogenesis[J]. Virus research, 2002, 89(2): 191-199.
|
12 |
刘萍. 中国大陆13年宫颈癌临床流行病学大数据评价[J]. 中国实用妇科与产科杂志, 2018, 34(1): 41-45.
|
13 |
田凌君. 12691例山西大医院妇产科门诊就诊患者HPV感染的调查研究[D]. 太原: 山西医科大学, 2017.
|
14 |
任妹, 何雯, 夏洪娇. 人乳头瘤病毒感染及亚型检测应用研究进展[J]. 检验医学与临床, 2019, 16(5): 710-713.
|
15 |
GUAN P, HOWELL-JONES R, LI N, et al. Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer[J]. International journal of cancer, 2012, 131(10): 2349-2359.
|
16 |
李爱敏, 李芳芳, 唐曙明,等. 不同年龄段女性宫颈人乳头状瘤病毒感染状况分析[J].中国卫生检验杂志, 2015, 25(10): 1652-1654, 1657.
|
17 |
罗慧琴, 王志刚, 李玲, 等. 太原地区HPV感染基因型分布与不同年龄段的相关性研究[J]. 国际检验医学杂志, 2012, 33(21): 2602-2603, 2605.
|
18 |
ZHU X, WANG Y, LV Z, et al. Prevalence and genotype distribution of high-risk HPV infection among women in Beijing, China[J]. Journal of medical virology, 2021, 93(8): 5103-5109.
|
19 |
GALLEGOS-BOLAÑOS J, RIVERA-DOMÍNGUEZ J A, PRESNO-BERNAL J M, et al. High prevalence of co-infection between human papillomavirus (HPV) 51 and 52 in Mexican population[J]. BMC cancer, 2017, 17(1): 531.
|